Search Results - jan+pohl

2 Results Sort By:
Linear Epitopes of Anthrax Toxin Protective Antigen for Development of a Peptide Vaccine
Bacillus anthracis is a gram-positive, spore-forming bacteria that causes anthrax infection in humans. CDC inventors have identified epitope sequences of B. anthracis protective antigen (PA) that may be useful for development of peptide-based anthrax vaccines. This invention also relates to methods for determining whether post-vaccination protection...
Published: 10/28/2024   |   Inventor(s): Conrad Quinn, Jan Pohl, Pavel Svoboda, Shannon Dalton, Jarad Schiffer, Stephen Soroka, Vera Semenova
Keywords(s): Anthrax, ANTIGEN, Bacillus, biosecurity, Bioterrism, Bio-terrorism, Bioterrorist, BioWarfare, CDC Docket Import, CDC Docket Import CDC Prosecuting, DC1XXX, DC4XXX, DCXXXX, Development, DXXXXX, Epitopes, LINEAR, OID-NCIRD-DBD, PA, Peptide, Protection, Protective, toxin, Vaccine
Category(s): Collaboration Sought > Licensing, Application > Vaccines, TherapeuticArea > Infectious Disease
Clinical Assay Predicts Outcomes Based on Enzyme Activity
Application Clinical assay to predict therapeutic outcomes based on kinase or phostphatase activity. Key Benefits Eliminates inconsistencies stemming from variable baseline activity. Selective measurement of specific enzymatic activity within a heterogeneous sample. Technical Summary Researchers at Emory University have developed assays to...
Published: 9/26/2024   |   Inventor(s): Jennifer Gooch, Jan Pohl, Brian Roberts
Keywords(s): Assay, Immunology/Inflammation
Category(s): TechPub Algolia > Diagnostics